178311-90-5

Basic information

• Product Name: 4-Piperidinecarboxylic acid,1-[1-(diphenylmethyl)-3-azetidinyl]-,ethyl ester
• Synonyms: 4-Piperidinecarboxylic acid,1-[1-(diphenylmethyl)-3-azetidinyl]-,ethyl ester;1-[1-(diphenylmethyl)-3-azetidinyl]-4-Piperidinecarboxylic acid ethyl ester
• CAS NO: 178311-90-5
• Molecular Formula: C24H30N2O2
• Molecular Weight: 378.5072
• Mol File: 178311-90-5.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-Piperidinecarboxylic acid,1-[1-(diphenylmethyl)-3-azetidinyl]-,ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Piperidinecarboxylic acid,1-[1-(diphenylmethyl)-3-azetidinyl]-,ethyl ester(178311-90-5)
• EPA Substance Registry System: 4-Piperidinecarboxylic acid,1-[1-(diphenylmethyl)-3-azetidinyl]-,ethyl ester(178311-90-5)

Safety Data

• Hazardous Substances Data: 178311-90-5(Hazardous Substances Data)

Upstream product

• 18621-17-5 1-(diphenylmethyl)-3-hydroxyazetidine 
• 1126-09-6 4-carbethoxypiperidine 
• 33301-41-6 1-benzhydryl-3-azetidinyl methanesulfonate 

Relevant articles and documents

NOVEL AROMATIC COMPOUND AND USE THEREOF

Provided is a compound showing a bone formation promoting action (and/or bone resorption suppressive action). A compound of the formula (I) or a pharmacologically acceptable salt: [wherein each substituent is as defined in the DESCRIPTION], has low toxicity, shows good pharmacokinetics, has an action to promote bone formation, and is useful for the prophylaxis or To treatment of metabolic bone diseases (osteoporosis, fibrous osteitis (hyperparathyroidism), osteomalacia, Paget's disease that influences the systemic bone metabolism parameter etc.) associated with a decrease in the bone formation ability as compared to the bone resorption capacity.